JONES DAY TALKS®: The CNPV Pilot Program – FDA’s High-Speed Lane for Drug Approval
About this episode
This episode discusses the CNPV Pilot Program and its impact on drug approval times.
In one of the most aggressive regulatory shake-ups in modern pharmaceutical history, the Commissioner’s National Priority Voucher Pilot Program, or CNPV, can dramatically reduce approval times for new drug introductions. Jones Day’s Jessica Tierney and Melissa Mannion explain how the program works and what potential applicants need to know.
People in this episode
Host: Jones Day
Guests: Jessica Tierney, Melissa Mannion
Topics covered
- drug approval
- pharmaceutical regulation
- CNPV Pilot Program
- healthcare
- government policy
Keywords
- CNPV
- drug approval
- FDA
- pharmaceuticals
- regulatory changes
Mentioned in this episode
Organizations: FDA
More episodes of Jones Day Talks
- JONES DAY TALKS®: Why Clients Need a Global Class Actions Defence Team
- JONES DAY TALKS®: Perspectives and Pathways Conference Delivers Career Guidance to Top Law School Talent
- JONES DAY TALKS®: Women in IP – Supreme Court Denies Review of Thaler v. Perlmutter: AI Authorship Questions Remain
- JONES DAY TALKS®: Perspectives and Pathways: Becoming a Lawyer and Building Your Professional Brand
- JONES DAY TALKS®: Real Assets Roundup – Episode 6: Higher Education
- JONES DAY TALKS®: Protecting the Crown Jewels: IP Due Diligence in Venture Capital Financings
Explore listener stats, chart rankings, contacts and more on the Jones Day Talks podcast page.